This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

BioTalk

2 results for: life science

2/19/2025 2:57:21 PM

Increased risks for Australian life sciences businesses under the EU’s modernised product liability regime

By Rebecca Currey Tom Johnston

A recent EU directive will have significant consequences for Australian life sciences companies operating in Europe. Directive 2024/2853...

11/26/2024 2:22:35 PM

By James Baillieu Fiona McFarlane

The amount of capital required to develop and bring a drug to market is significant. It is estimated that it costs US$1-2 billion to...